3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Primary Myelofibrosis
1
Myelodysplastic Syndromes
1
Leukemia, Myeloid, Acute
1
Interventions
Blood Specimen Collection
27
Surveys and Questionnaires
24
Magnetic Resonance Spectroscopy
10
Observation
7
Flow Cytometry
7
Specimen Handling
6
Amplified Fragment Length Polymorphism Analysis
6
exemestane
5
Radiotherapy
5
Magnetic Resonance Imaging
5
Immunoenzyme Techniques
5
Biopsy
5
Radiation
4
Neoadjuvant Therapy
4
Mental Status and Dementia Tests
4
Genetic Testing
4
Gene Expression Profiling
4
Electroporation
4
Data Collection
4
Bevacizumab
4
Trastuzumab
3
Tomography, X-Ray Computed
3
Tomography, Optical Coherence
3
Therapeutics
3
Surgical Procedures, Operative
3
Sunitinib
3
Sorafenib
3
Registries
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Observational
×
luspatercept
×
Clear all
NCT01688011
2025-07-03
Connect® Myeloid Disease Registry
Celgene
Terminated
2,013 enrolled